Chemical & Material
Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Mar 27, 25
- ID: 159518
- Pages: 76
- Figures: 77
- Views: 32
The global Hirudin market size was US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.
The global Hirudin market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm
By Type: (Dominant Segment vs High-Margin Innovation)
Natural Hirudin
Recombinant Hirudin
By Application: (Core Demand Driver vs Emerging Opportunity)
Thrombosis Disease
Tumor Disease
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., The Medicines Company in Europe)
- Emerging Product Trends: Natural Hirudin adoption vs. Recombinant Hirudin premiumization
- Demand-Side Dynamics: Thrombosis Disease growth in China vs. Tumor Disease potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Hirudin market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Recombinant Hirudin in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Tumor Disease in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Hirudin value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.
The global Hirudin market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm
By Type: (Dominant Segment vs High-Margin Innovation)
Natural Hirudin
Recombinant Hirudin
By Application: (Core Demand Driver vs Emerging Opportunity)
Thrombosis Disease
Tumor Disease
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., The Medicines Company in Europe)
- Emerging Product Trends: Natural Hirudin adoption vs. Recombinant Hirudin premiumization
- Demand-Side Dynamics: Thrombosis Disease growth in China vs. Tumor Disease potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Hirudin market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Recombinant Hirudin in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Tumor Disease in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Hirudin value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Market Overview
1.1 Hirudin Product Scope
1.2 Hirudin by Type
1.2.1 Global Hirudin Sales by Type (2020 & 2024 & 2031)
1.2.2 Natural Hirudin
1.2.3 Recombinant Hirudin
1.3 Hirudin by Application
1.3.1 Global Hirudin Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Thrombosis Disease
1.3.3 Tumor Disease
1.3.4 Others
1.4 Global Hirudin Market Estimates and Forecasts (2020-2031)
1.4.1 Global Hirudin Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Hirudin Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Hirudin Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Hirudin Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Hirudin Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Hirudin Sales Market Share by Region (2020-2025)
2.2.2 Global Hirudin Revenue Market Share by Region (2020-2025)
2.3 Global Hirudin Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Hirudin Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Hirudin Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Hirudin Market Size and Prospective (2020-2031)
2.4.2 Europe Hirudin Market Size and Prospective (2020-2031)
2.4.3 China Hirudin Market Size and Prospective (2020-2031)
2.4.4 Japan Hirudin Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Hirudin Historic Market Review by Type (2020-2025)
3.1.1 Global Hirudin Sales by Type (2020-2025)
3.1.2 Global Hirudin Revenue by Type (2020-2025)
3.1.3 Global Hirudin Price by Type (2020-2025)
3.2 Global Hirudin Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Hirudin Sales Forecast by Type (2026-2031)
3.2.2 Global Hirudin Revenue Forecast by Type (2026-2031)
3.2.3 Global Hirudin Price Forecast by Type (2026-2031)
3.3 Different Types Hirudin Representative Players
4 Global Market Size by Application
4.1 Global Hirudin Historic Market Review by Application (2020-2025)
4.1.1 Global Hirudin Sales by Application (2020-2025)
4.1.2 Global Hirudin Revenue by Application (2020-2025)
4.1.3 Global Hirudin Price by Application (2020-2025)
4.2 Global Hirudin Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Hirudin Sales Forecast by Application (2026-2031)
4.2.2 Global Hirudin Revenue Forecast by Application (2026-2031)
4.2.3 Global Hirudin Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Hirudin Application
5 Competition Landscape by Players
5.1 Global Hirudin Sales by Players (2020-2025)
5.2 Global Top Hirudin Players by Revenue (2020-2025)
5.3 Global Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hirudin as of 2024)
5.4 Global Hirudin Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Hirudin, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Hirudin, Product Type & Application
5.7 Global Key Manufacturers of Hirudin, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Hirudin Sales by Company
6.1.1.1 North America Hirudin Sales by Company (2020-2025)
6.1.1.2 North America Hirudin Revenue by Company (2020-2025)
6.1.2 North America Hirudin Sales Breakdown by Type (2020-2025)
6.1.3 North America Hirudin Sales Breakdown by Application (2020-2025)
6.1.4 North America Hirudin Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Hirudin Sales by Company
6.2.1.1 Europe Hirudin Sales by Company (2020-2025)
6.2.1.2 Europe Hirudin Revenue by Company (2020-2025)
6.2.2 Europe Hirudin Sales Breakdown by Type (2020-2025)
6.2.3 Europe Hirudin Sales Breakdown by Application (2020-2025)
6.2.4 Europe Hirudin Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Hirudin Sales by Company
6.3.1.1 China Hirudin Sales by Company (2020-2025)
6.3.1.2 China Hirudin Revenue by Company (2020-2025)
6.3.2 China Hirudin Sales Breakdown by Type (2020-2025)
6.3.3 China Hirudin Sales Breakdown by Application (2020-2025)
6.3.4 China Hirudin Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Hirudin Sales by Company
6.4.1.1 Japan Hirudin Sales by Company (2020-2025)
6.4.1.2 Japan Hirudin Revenue by Company (2020-2025)
6.4.2 Japan Hirudin Sales Breakdown by Type (2020-2025)
6.4.3 Japan Hirudin Sales Breakdown by Application (2020-2025)
6.4.4 Japan Hirudin Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 The Medicines Company
7.1.1 The Medicines Company Company Information
7.1.2 The Medicines Company Business Overview
7.1.3 The Medicines Company Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.1.4 The Medicines Company Hirudin Products Offered
7.1.5 The Medicines Company Recent Development
7.2 Keyken
7.2.1 Keyken Company Information
7.2.2 Keyken Business Overview
7.2.3 Keyken Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Keyken Hirudin Products Offered
7.2.5 Keyken Recent Development
7.3 Minapharm
7.3.1 Minapharm Company Information
7.3.2 Minapharm Business Overview
7.3.3 Minapharm Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Minapharm Hirudin Products Offered
7.3.5 Minapharm Recent Development
7.4 Abbott
7.4.1 Abbott Company Information
7.4.2 Abbott Business Overview
7.4.3 Abbott Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Abbott Hirudin Products Offered
7.4.5 Abbott Recent Development
7.5 SALUBRIS
7.5.1 SALUBRIS Company Information
7.5.2 SALUBRIS Business Overview
7.5.3 SALUBRIS Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.5.4 SALUBRIS Hirudin Products Offered
7.5.5 SALUBRIS Recent Development
7.6 Pfizer, Inc
7.6.1 Pfizer, Inc Company Information
7.6.2 Pfizer, Inc Business Overview
7.6.3 Pfizer, Inc Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Pfizer, Inc Hirudin Products Offered
7.6.5 Pfizer, Inc Recent Development
7.7 Teva Pharmaceutical Industries Ltd
7.7.1 Teva Pharmaceutical Industries Ltd Company Information
7.7.2 Teva Pharmaceutical Industries Ltd Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Teva Pharmaceutical Industries Ltd Hirudin Products Offered
7.7.5 Teva Pharmaceutical Industries Ltd Recent Development
7.8 DUOPUTAI
7.8.1 DUOPUTAI Company Information
7.8.2 DUOPUTAI Business Overview
7.8.3 DUOPUTAI Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.8.4 DUOPUTAI Hirudin Products Offered
7.8.5 DUOPUTAI Recent Development
7.9 Pentapharm
7.9.1 Pentapharm Company Information
7.9.2 Pentapharm Business Overview
7.9.3 Pentapharm Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Pentapharm Hirudin Products Offered
7.9.5 Pentapharm Recent Development
8 Hirudin Manufacturing Cost Analysis
8.1 Hirudin Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Hirudin
8.4 Hirudin Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Hirudin Distributors List
9.3 Hirudin Customers
10 Hirudin Market Dynamics
10.1 Hirudin Industry Trends
10.2 Hirudin Market Drivers
10.3 Hirudin Market Challenges
10.4 Hirudin Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Hirudin Product Scope
1.2 Hirudin by Type
1.2.1 Global Hirudin Sales by Type (2020 & 2024 & 2031)
1.2.2 Natural Hirudin
1.2.3 Recombinant Hirudin
1.3 Hirudin by Application
1.3.1 Global Hirudin Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Thrombosis Disease
1.3.3 Tumor Disease
1.3.4 Others
1.4 Global Hirudin Market Estimates and Forecasts (2020-2031)
1.4.1 Global Hirudin Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Hirudin Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Hirudin Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Hirudin Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Hirudin Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Hirudin Sales Market Share by Region (2020-2025)
2.2.2 Global Hirudin Revenue Market Share by Region (2020-2025)
2.3 Global Hirudin Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Hirudin Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Hirudin Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Hirudin Market Size and Prospective (2020-2031)
2.4.2 Europe Hirudin Market Size and Prospective (2020-2031)
2.4.3 China Hirudin Market Size and Prospective (2020-2031)
2.4.4 Japan Hirudin Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Hirudin Historic Market Review by Type (2020-2025)
3.1.1 Global Hirudin Sales by Type (2020-2025)
3.1.2 Global Hirudin Revenue by Type (2020-2025)
3.1.3 Global Hirudin Price by Type (2020-2025)
3.2 Global Hirudin Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Hirudin Sales Forecast by Type (2026-2031)
3.2.2 Global Hirudin Revenue Forecast by Type (2026-2031)
3.2.3 Global Hirudin Price Forecast by Type (2026-2031)
3.3 Different Types Hirudin Representative Players
4 Global Market Size by Application
4.1 Global Hirudin Historic Market Review by Application (2020-2025)
4.1.1 Global Hirudin Sales by Application (2020-2025)
4.1.2 Global Hirudin Revenue by Application (2020-2025)
4.1.3 Global Hirudin Price by Application (2020-2025)
4.2 Global Hirudin Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Hirudin Sales Forecast by Application (2026-2031)
4.2.2 Global Hirudin Revenue Forecast by Application (2026-2031)
4.2.3 Global Hirudin Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Hirudin Application
5 Competition Landscape by Players
5.1 Global Hirudin Sales by Players (2020-2025)
5.2 Global Top Hirudin Players by Revenue (2020-2025)
5.3 Global Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hirudin as of 2024)
5.4 Global Hirudin Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Hirudin, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Hirudin, Product Type & Application
5.7 Global Key Manufacturers of Hirudin, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Hirudin Sales by Company
6.1.1.1 North America Hirudin Sales by Company (2020-2025)
6.1.1.2 North America Hirudin Revenue by Company (2020-2025)
6.1.2 North America Hirudin Sales Breakdown by Type (2020-2025)
6.1.3 North America Hirudin Sales Breakdown by Application (2020-2025)
6.1.4 North America Hirudin Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Hirudin Sales by Company
6.2.1.1 Europe Hirudin Sales by Company (2020-2025)
6.2.1.2 Europe Hirudin Revenue by Company (2020-2025)
6.2.2 Europe Hirudin Sales Breakdown by Type (2020-2025)
6.2.3 Europe Hirudin Sales Breakdown by Application (2020-2025)
6.2.4 Europe Hirudin Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Hirudin Sales by Company
6.3.1.1 China Hirudin Sales by Company (2020-2025)
6.3.1.2 China Hirudin Revenue by Company (2020-2025)
6.3.2 China Hirudin Sales Breakdown by Type (2020-2025)
6.3.3 China Hirudin Sales Breakdown by Application (2020-2025)
6.3.4 China Hirudin Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Hirudin Sales by Company
6.4.1.1 Japan Hirudin Sales by Company (2020-2025)
6.4.1.2 Japan Hirudin Revenue by Company (2020-2025)
6.4.2 Japan Hirudin Sales Breakdown by Type (2020-2025)
6.4.3 Japan Hirudin Sales Breakdown by Application (2020-2025)
6.4.4 Japan Hirudin Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 The Medicines Company
7.1.1 The Medicines Company Company Information
7.1.2 The Medicines Company Business Overview
7.1.3 The Medicines Company Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.1.4 The Medicines Company Hirudin Products Offered
7.1.5 The Medicines Company Recent Development
7.2 Keyken
7.2.1 Keyken Company Information
7.2.2 Keyken Business Overview
7.2.3 Keyken Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Keyken Hirudin Products Offered
7.2.5 Keyken Recent Development
7.3 Minapharm
7.3.1 Minapharm Company Information
7.3.2 Minapharm Business Overview
7.3.3 Minapharm Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Minapharm Hirudin Products Offered
7.3.5 Minapharm Recent Development
7.4 Abbott
7.4.1 Abbott Company Information
7.4.2 Abbott Business Overview
7.4.3 Abbott Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Abbott Hirudin Products Offered
7.4.5 Abbott Recent Development
7.5 SALUBRIS
7.5.1 SALUBRIS Company Information
7.5.2 SALUBRIS Business Overview
7.5.3 SALUBRIS Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.5.4 SALUBRIS Hirudin Products Offered
7.5.5 SALUBRIS Recent Development
7.6 Pfizer, Inc
7.6.1 Pfizer, Inc Company Information
7.6.2 Pfizer, Inc Business Overview
7.6.3 Pfizer, Inc Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Pfizer, Inc Hirudin Products Offered
7.6.5 Pfizer, Inc Recent Development
7.7 Teva Pharmaceutical Industries Ltd
7.7.1 Teva Pharmaceutical Industries Ltd Company Information
7.7.2 Teva Pharmaceutical Industries Ltd Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Teva Pharmaceutical Industries Ltd Hirudin Products Offered
7.7.5 Teva Pharmaceutical Industries Ltd Recent Development
7.8 DUOPUTAI
7.8.1 DUOPUTAI Company Information
7.8.2 DUOPUTAI Business Overview
7.8.3 DUOPUTAI Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.8.4 DUOPUTAI Hirudin Products Offered
7.8.5 DUOPUTAI Recent Development
7.9 Pentapharm
7.9.1 Pentapharm Company Information
7.9.2 Pentapharm Business Overview
7.9.3 Pentapharm Hirudin Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Pentapharm Hirudin Products Offered
7.9.5 Pentapharm Recent Development
8 Hirudin Manufacturing Cost Analysis
8.1 Hirudin Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Hirudin
8.4 Hirudin Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Hirudin Distributors List
9.3 Hirudin Customers
10 Hirudin Market Dynamics
10.1 Hirudin Industry Trends
10.2 Hirudin Market Drivers
10.3 Hirudin Market Challenges
10.4 Hirudin Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Hirudin Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Hirudin Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Hirudin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Hirudin Sales (K MT) by Region (2020-2025)
Table 5. Global Hirudin Sales Market Share by Region (2020-2025)
Table 6. Global Hirudin Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Hirudin Revenue Share by Region (2020-2025)
Table 8. Global Hirudin Sales (K MT) Forecast by Region (2026-2031)
Table 9. Global Hirudin Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Hirudin Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Hirudin Revenue Share Forecast by Region (2026-2031)
Table 12. Global Hirudin Sales by Type (K MT) & (2020-2025)
Table 13. Global Hirudin Sales Share by Type (2020-2025)
Table 14. Global Hirudin Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Hirudin Price by Type (USD/MT) & (2020-2025)
Table 16. Global Hirudin Sales by Type (K MT) & (2026-2031)
Table 17. Global Hirudin Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Hirudin Price by Type (USD/MT) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Hirudin Sales by Application (K MT) & (2020-2025)
Table 21. Global Hirudin Sales Share by Application (2020-2025)
Table 22. Global Hirudin Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Hirudin Price by Application (USD/MT) & (2020-2025)
Table 24. Global Hirudin Sales by Application (K MT) & (2026-2031)
Table 25. Global Hirudin Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Hirudin Price by Application (USD/MT) & (2026-2031)
Table 27. New Sources of Growth in Hirudin Application
Table 28. Global Hirudin Sales by Company (K MT) & (2020-2025)
Table 29. Global Hirudin Sales Share by Company (2020-2025)
Table 30. Global Hirudin Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Hirudin Revenue Share by Company (2020-2025)
Table 32. Global Hirudin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hirudin as of 2024)
Table 33. Global Market Hirudin Average Price by Company (USD/MT) & (2020-2025)
Table 34. Global Key Manufacturers of Hirudin, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Hirudin, Product Type & Application
Table 36. Global Key Manufacturers of Hirudin, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Hirudin Sales by Company (2020-2025) & (K MT)
Table 39. North America Hirudin Sales Market Share by Company (2020-2025)
Table 40. North America Hirudin Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Hirudin Revenue Market Share by Company (2020-2025)
Table 42. North America Hirudin Sales by Type (2020-2025) & (K MT)
Table 43. North America Hirudin Sales Market Share by Type (2020-2025)
Table 44. North America Hirudin Sales by Application (2020-2025) & (K MT)
Table 45. North America Hirudin Sales Market Share by Application (2020-2025)
Table 46. Europe Hirudin Sales by Company (2020-2025) & (K MT)
Table 47. Europe Hirudin Sales Market Share by Company (2020-2025)
Table 48. Europe Hirudin Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Hirudin Revenue Market Share by Company (2020-2025)
Table 50. Europe Hirudin Sales by Type (2020-2025) & (K MT)
Table 51. Europe Hirudin Sales Market Share by Type (2020-2025)
Table 52. Europe Hirudin Sales by Application (2020-2025) & (K MT)
Table 53. Europe Hirudin Sales Market Share by Application (2020-2025)
Table 54. China Hirudin Sales by Company (2020-2025) & (K MT)
Table 55. China Hirudin Sales Market Share by Company (2020-2025)
Table 56. China Hirudin Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Hirudin Revenue Market Share by Company (2020-2025)
Table 58. China Hirudin Sales by Type (2020-2025) & (K MT)
Table 59. China Hirudin Sales Market Share by Type (2020-2025)
Table 60. China Hirudin Sales by Application (2020-2025) & (K MT)
Table 61. China Hirudin Sales Market Share by Application (2020-2025)
Table 62. Japan Hirudin Sales by Company (2020-2025) & (K MT)
Table 63. Japan Hirudin Sales Market Share by Company (2020-2025)
Table 64. Japan Hirudin Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Hirudin Revenue Market Share by Company (2020-2025)
Table 66. Japan Hirudin Sales by Type (2020-2025) & (K MT)
Table 67. Japan Hirudin Sales Market Share by Type (2020-2025)
Table 68. Japan Hirudin Sales by Application (2020-2025) & (K MT)
Table 69. Japan Hirudin Sales Market Share by Application (2020-2025)
Table 70. The Medicines Company Company Information
Table 71. The Medicines Company Description and Business Overview
Table 72. The Medicines Company Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. The Medicines Company Hirudin Product
Table 74. The Medicines Company Recent Development
Table 75. Keyken Company Information
Table 76. Keyken Description and Business Overview
Table 77. Keyken Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Keyken Hirudin Product
Table 79. Keyken Recent Development
Table 80. Minapharm Company Information
Table 81. Minapharm Description and Business Overview
Table 82. Minapharm Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. Minapharm Hirudin Product
Table 84. Minapharm Recent Development
Table 85. Abbott Company Information
Table 86. Abbott Description and Business Overview
Table 87. Abbott Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Abbott Hirudin Product
Table 89. Abbott Recent Development
Table 90. SALUBRIS Company Information
Table 91. SALUBRIS Description and Business Overview
Table 92. SALUBRIS Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. SALUBRIS Hirudin Product
Table 94. SALUBRIS Recent Development
Table 95. Pfizer, Inc Company Information
Table 96. Pfizer, Inc Description and Business Overview
Table 97. Pfizer, Inc Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. Pfizer, Inc Hirudin Product
Table 99. Pfizer, Inc Recent Development
Table 100. Teva Pharmaceutical Industries Ltd Company Information
Table 101. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 102. Teva Pharmaceutical Industries Ltd Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Teva Pharmaceutical Industries Ltd Hirudin Product
Table 104. Teva Pharmaceutical Industries Ltd Recent Development
Table 105. DUOPUTAI Company Information
Table 106. DUOPUTAI Description and Business Overview
Table 107. DUOPUTAI Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. DUOPUTAI Hirudin Product
Table 109. DUOPUTAI Recent Development
Table 110. Pentapharm Company Information
Table 111. Pentapharm Description and Business Overview
Table 112. Pentapharm Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Pentapharm Hirudin Product
Table 114. Pentapharm Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Hirudin Distributors List
Table 118. Hirudin Customers List
Table 119. Hirudin Market Trends
Table 120. Hirudin Market Drivers
Table 121. Hirudin Market Challenges
Table 122. Hirudin Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Hirudin Product Picture
Figure 2. Global Hirudin Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Hirudin Sales Market Share by Type in 2024 & 2031
Figure 4. Natural Hirudin Product Picture
Figure 5. Recombinant Hirudin Product Picture
Figure 6. Global Hirudin Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Hirudin Sales Market Share by Application in 2024 & 2031
Figure 8. Thrombosis Disease Examples
Figure 9. Tumor Disease Examples
Figure 10. Others Examples
Figure 11. Global Hirudin Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Hirudin Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Hirudin Sales (K MT) Growth Rate (2020-2031)
Figure 14. Global Hirudin Price Trends Growth Rate (2020-2031) & (USD/MT)
Figure 15. Hirudin Report Years Considered
Figure 16. Global Market Hirudin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Hirudin Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Hirudin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Hirudin Sales (K MT) Growth Rate (2020-2031)
Figure 20. Europe Hirudin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Hirudin Sales (K MT) Growth Rate (2020-2031)
Figure 22. China Hirudin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Hirudin Sales (K MT) Growth Rate (2020-2031)
Figure 24. Japan Hirudin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Hirudin Sales (K MT) Growth Rate (2020-2031)
Figure 26. Global Hirudin Revenue Share by Type (2020-2025)
Figure 27. Global Hirudin Sales Share by Type (2026-2031)
Figure 28. Global Hirudin Revenue Share by Type (2026-2031)
Figure 29. Global Hirudin Revenue Share by Application (2020-2025)
Figure 30. Global Hirudin Revenue Growth Rate by Application in 2020 & 2024
Figure 31. Global Hirudin Sales Share by Application (2026-2031)
Figure 32. Global Hirudin Revenue Share by Application (2026-2031)
Figure 33. Global Hirudin Sales Share by Company (2024)
Figure 34. Global Hirudin Revenue Share by Company (2024)
Figure 35. Global 5 Largest Hirudin Players Market Share by Revenue in Hirudin: 2020 & 2024
Figure 36. Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 37. Manufacturing Cost Structure of Hirudin
Figure 38. Manufacturing Process Analysis of Hirudin
Figure 39. Hirudin Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
Table 1. Global Hirudin Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Hirudin Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Hirudin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Hirudin Sales (K MT) by Region (2020-2025)
Table 5. Global Hirudin Sales Market Share by Region (2020-2025)
Table 6. Global Hirudin Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Hirudin Revenue Share by Region (2020-2025)
Table 8. Global Hirudin Sales (K MT) Forecast by Region (2026-2031)
Table 9. Global Hirudin Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Hirudin Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Hirudin Revenue Share Forecast by Region (2026-2031)
Table 12. Global Hirudin Sales by Type (K MT) & (2020-2025)
Table 13. Global Hirudin Sales Share by Type (2020-2025)
Table 14. Global Hirudin Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Hirudin Price by Type (USD/MT) & (2020-2025)
Table 16. Global Hirudin Sales by Type (K MT) & (2026-2031)
Table 17. Global Hirudin Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Hirudin Price by Type (USD/MT) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Hirudin Sales by Application (K MT) & (2020-2025)
Table 21. Global Hirudin Sales Share by Application (2020-2025)
Table 22. Global Hirudin Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Hirudin Price by Application (USD/MT) & (2020-2025)
Table 24. Global Hirudin Sales by Application (K MT) & (2026-2031)
Table 25. Global Hirudin Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Hirudin Price by Application (USD/MT) & (2026-2031)
Table 27. New Sources of Growth in Hirudin Application
Table 28. Global Hirudin Sales by Company (K MT) & (2020-2025)
Table 29. Global Hirudin Sales Share by Company (2020-2025)
Table 30. Global Hirudin Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Hirudin Revenue Share by Company (2020-2025)
Table 32. Global Hirudin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hirudin as of 2024)
Table 33. Global Market Hirudin Average Price by Company (USD/MT) & (2020-2025)
Table 34. Global Key Manufacturers of Hirudin, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Hirudin, Product Type & Application
Table 36. Global Key Manufacturers of Hirudin, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Hirudin Sales by Company (2020-2025) & (K MT)
Table 39. North America Hirudin Sales Market Share by Company (2020-2025)
Table 40. North America Hirudin Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Hirudin Revenue Market Share by Company (2020-2025)
Table 42. North America Hirudin Sales by Type (2020-2025) & (K MT)
Table 43. North America Hirudin Sales Market Share by Type (2020-2025)
Table 44. North America Hirudin Sales by Application (2020-2025) & (K MT)
Table 45. North America Hirudin Sales Market Share by Application (2020-2025)
Table 46. Europe Hirudin Sales by Company (2020-2025) & (K MT)
Table 47. Europe Hirudin Sales Market Share by Company (2020-2025)
Table 48. Europe Hirudin Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Hirudin Revenue Market Share by Company (2020-2025)
Table 50. Europe Hirudin Sales by Type (2020-2025) & (K MT)
Table 51. Europe Hirudin Sales Market Share by Type (2020-2025)
Table 52. Europe Hirudin Sales by Application (2020-2025) & (K MT)
Table 53. Europe Hirudin Sales Market Share by Application (2020-2025)
Table 54. China Hirudin Sales by Company (2020-2025) & (K MT)
Table 55. China Hirudin Sales Market Share by Company (2020-2025)
Table 56. China Hirudin Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Hirudin Revenue Market Share by Company (2020-2025)
Table 58. China Hirudin Sales by Type (2020-2025) & (K MT)
Table 59. China Hirudin Sales Market Share by Type (2020-2025)
Table 60. China Hirudin Sales by Application (2020-2025) & (K MT)
Table 61. China Hirudin Sales Market Share by Application (2020-2025)
Table 62. Japan Hirudin Sales by Company (2020-2025) & (K MT)
Table 63. Japan Hirudin Sales Market Share by Company (2020-2025)
Table 64. Japan Hirudin Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Hirudin Revenue Market Share by Company (2020-2025)
Table 66. Japan Hirudin Sales by Type (2020-2025) & (K MT)
Table 67. Japan Hirudin Sales Market Share by Type (2020-2025)
Table 68. Japan Hirudin Sales by Application (2020-2025) & (K MT)
Table 69. Japan Hirudin Sales Market Share by Application (2020-2025)
Table 70. The Medicines Company Company Information
Table 71. The Medicines Company Description and Business Overview
Table 72. The Medicines Company Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. The Medicines Company Hirudin Product
Table 74. The Medicines Company Recent Development
Table 75. Keyken Company Information
Table 76. Keyken Description and Business Overview
Table 77. Keyken Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Keyken Hirudin Product
Table 79. Keyken Recent Development
Table 80. Minapharm Company Information
Table 81. Minapharm Description and Business Overview
Table 82. Minapharm Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. Minapharm Hirudin Product
Table 84. Minapharm Recent Development
Table 85. Abbott Company Information
Table 86. Abbott Description and Business Overview
Table 87. Abbott Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Abbott Hirudin Product
Table 89. Abbott Recent Development
Table 90. SALUBRIS Company Information
Table 91. SALUBRIS Description and Business Overview
Table 92. SALUBRIS Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. SALUBRIS Hirudin Product
Table 94. SALUBRIS Recent Development
Table 95. Pfizer, Inc Company Information
Table 96. Pfizer, Inc Description and Business Overview
Table 97. Pfizer, Inc Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. Pfizer, Inc Hirudin Product
Table 99. Pfizer, Inc Recent Development
Table 100. Teva Pharmaceutical Industries Ltd Company Information
Table 101. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 102. Teva Pharmaceutical Industries Ltd Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Teva Pharmaceutical Industries Ltd Hirudin Product
Table 104. Teva Pharmaceutical Industries Ltd Recent Development
Table 105. DUOPUTAI Company Information
Table 106. DUOPUTAI Description and Business Overview
Table 107. DUOPUTAI Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. DUOPUTAI Hirudin Product
Table 109. DUOPUTAI Recent Development
Table 110. Pentapharm Company Information
Table 111. Pentapharm Description and Business Overview
Table 112. Pentapharm Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Pentapharm Hirudin Product
Table 114. Pentapharm Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Hirudin Distributors List
Table 118. Hirudin Customers List
Table 119. Hirudin Market Trends
Table 120. Hirudin Market Drivers
Table 121. Hirudin Market Challenges
Table 122. Hirudin Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Hirudin Product Picture
Figure 2. Global Hirudin Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Hirudin Sales Market Share by Type in 2024 & 2031
Figure 4. Natural Hirudin Product Picture
Figure 5. Recombinant Hirudin Product Picture
Figure 6. Global Hirudin Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Hirudin Sales Market Share by Application in 2024 & 2031
Figure 8. Thrombosis Disease Examples
Figure 9. Tumor Disease Examples
Figure 10. Others Examples
Figure 11. Global Hirudin Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Hirudin Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Hirudin Sales (K MT) Growth Rate (2020-2031)
Figure 14. Global Hirudin Price Trends Growth Rate (2020-2031) & (USD/MT)
Figure 15. Hirudin Report Years Considered
Figure 16. Global Market Hirudin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Hirudin Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Hirudin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Hirudin Sales (K MT) Growth Rate (2020-2031)
Figure 20. Europe Hirudin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Hirudin Sales (K MT) Growth Rate (2020-2031)
Figure 22. China Hirudin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Hirudin Sales (K MT) Growth Rate (2020-2031)
Figure 24. Japan Hirudin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Hirudin Sales (K MT) Growth Rate (2020-2031)
Figure 26. Global Hirudin Revenue Share by Type (2020-2025)
Figure 27. Global Hirudin Sales Share by Type (2026-2031)
Figure 28. Global Hirudin Revenue Share by Type (2026-2031)
Figure 29. Global Hirudin Revenue Share by Application (2020-2025)
Figure 30. Global Hirudin Revenue Growth Rate by Application in 2020 & 2024
Figure 31. Global Hirudin Sales Share by Application (2026-2031)
Figure 32. Global Hirudin Revenue Share by Application (2026-2031)
Figure 33. Global Hirudin Sales Share by Company (2024)
Figure 34. Global Hirudin Revenue Share by Company (2024)
Figure 35. Global 5 Largest Hirudin Players Market Share by Revenue in Hirudin: 2020 & 2024
Figure 36. Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 37. Manufacturing Cost Structure of Hirudin
Figure 38. Manufacturing Process Analysis of Hirudin
Figure 39. Hirudin Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232